Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Friday, December 19, 2025
Advertising
About Us
Subscribe to Newsletter
Facebook
Twitter
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
Home
Authors
Posts by Life Sciences Times
Life Sciences Times
7730 POSTS
0 Comments
https://blstimes.com
Pharma
Delix Therapeutics Names Mark Rus as Chief Executive Officer
Life Sciences Times
-
March 18, 2021
0
Biotech
Waters new BioAccord System Boosts Innovator and Biosimilar Drug Development
Life Sciences Times
-
March 18, 2021
0
Real Estate
Lendlease and Ivanhoé Cambridge to Develop World-Class Life Science Project in Boston, Retain SGA to Design the Building
Life Sciences Times
-
March 18, 2021
0
Pharma
FSD Pharma Enters into License Agreement to Develop Veterinary Drugs for the Treatment of Dogs and Cats
Life Sciences Times
-
March 17, 2021
0
Life Sciences
Life Sciences Industry Looks to Digital Innovation to Help Navigate the Pandemic and Beyond
Life Sciences Times
-
March 17, 2021
0
Pharma
PerkinElmer Further Expands Capabilities in Biologics Drug Discovery
Life Sciences Times
-
March 17, 2021
0
Venture Capital
IDT Acquires Swift Biosciences
Life Sciences Times
-
March 12, 2021
0
Pharma
ViiV Healthcare presents positive proof-of-concept findings for a novel maturation inhibitor for the treatment of HIV
Life Sciences Times
-
March 9, 2021
0
Public Health
Has COVID Changed Spring Cleaning?
Life Sciences Times
-
March 9, 2021
0
Pharma
ReForm Biologics Announces the Issuance of Chinese Patent for Therapeutic Protein Formulations
Life Sciences Times
-
March 8, 2021
0
1
...
744
745
746
...
773
Page 745 of 773
TOP AUTHORS
Life Sciences Times
7730 POSTS
0 Comments
https://blstimes.com
Most Read
Manifold Raises $18 Million Series B to Expand Vertical AI Platform for Life Sciences
December 19, 2025
PureTech Appoints Robert Lyne as Chief Executive Officer
December 19, 2025
Orum Therapeutics Raises Approximately $100 Million to Advance Degrader Antibody Conjugate Programs
December 19, 2025
Syremis Therapeutics Launches With $165 Million Series A to Advance New Treatments for Mental Health Disorders
December 19, 2025